Susan E. Lyons

Susan E. Lyons

Auto-generated profile, based on publicly available information

Susan E. Lyons

†Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
FKFeng-Ming Kong
Feng-Ming Kong
JHJames A. Hayman
James A. Hayman
KGKent A. Griffith
Kent A. Griffith
GKGregory P. Kalemkerian
Gregory P. Kalemkerian
DADouglas Arenberg
Douglas Arenberg
RHRandall K. Ten Haken
Randall K. Ten Haken

1 July 2007 in Cell Host & Microbe
Verified
Journal Article
Closed access
HCHilary Clay
Hilary Clay
JDJ. Muse Davis
J. Muse Davis
DBDana Beery
Dana Beery
AHAnna Huttenlocher
Anna Huttenlocher
SLSusan E. Lyons
Susan E. Lyons
LRLalita Ramakrishnan
Lalita Ramakrishnan

1 March 1992 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SLS.E. Lyons
S.E. Lyons
MBM.E. Bruck
M.E. Bruck
EBE.J. Bowie
E.J. Bowie
DGD Ginsburg
D Ginsburg
Type IIA von Willebrand disease (vWD) results from abnormalities in von Willebrand factor (vWF) characterized by absence of plasma high molecular weight (HMW) vWF multimers. In this report, 5 distinct point mutations were identified in 6 Type IIA vWD families. A total of 7 mutations, all clustered within a 124-amino acid segment of the vWF A2 domain, now account for 9 of a panel of 11 Type IIA families. In COS-7 cells, 3 single amino acid substitutions, Val844----Asp, Ser743----Leu, and Gly742----Arg, impaired the transport of vWF multimers between the endoplasmic reticulum and the Golgi complex, with more profound effects on the secretion of HMW multimers than lower molecular weight forms. In contrast, 2 substitutions, Arg834----Trp and Gly742----Glu, resulted in secretion of HMW multimers similar to wild-type vWF. The vWF structure observed within patient platelets correlated closely with the synthesis pattern seen for the corresponding mutants in COS-7 cells. These findings demonstrate that structural alterations within the A2 domain of vWF can produce the characteristic phenotype of Type IIA vWD via two distinct molecular mechanisms.

16 April 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLSusan E. Lyons
Susan E. Lyons
NLNathan D. Lawson
Nathan D. Lawson
LLLin Lei
Lin Lei
PBPaul E. Bennett
Paul E. Bennett
BWBrant M. Weinstein
Brant M. Weinstein
PLP. Paul Liu
P. Paul Liu
Vlad tepes ( vlt m651 ) is one of only five “bloodless” zebrafish mutants isolated through large-scale chemical mutagenesis screening. It is characterized by a severe reduction in blood cell progenitors and few or no blood cells at the onset of circulation. We now report characterization of the mutant phenotype and the identification of the gene mutated in vlt m651 . Embryos homozygous for the vlt m651 mutation had normal expression of hematopoietic stem cell markers through 24 h postfertilization, as well as normal expression of myeloid and lymphoid markers. Analysis of erythroid development revealed variable expression of erythroid markers. Through positional and candidate gene cloning approaches we identified a nonsense mutation in the gata1 gene, 1015C → T (Arg-339 → Stop), in vlt m651 . The nonsense mutation was located C-terminal to the two zinc fingers and resulted in a truncated protein that was unable to bind DNA or mediate GATA-specific transactivation. A BAC clone containing the zebrafish gata1 gene was able to rescue the bloodless phenotype in vlt m651 . These results show that the vlt m651 mutation is a previously uncharacterized gata1 allele in the zebrafish. The vlt m651 mutation sheds new light on Gata1 structure and function in vivo , demonstrates that Gata1 plays an essential role in zebrafish hematopoiesis with significant conservation of function between mammals and zebrafish, and offers a powerful tool for future studies of the hematopoietic pathway.

28 August 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DBDavid Buchner
David Buchner
FSFengyun Su
Fengyun Su
JYJennifer S. Yamaoka
Jennifer S. Yamaoka
MKMakoto Kamei
Makoto Kamei
JSJordan A. Shavit
Jordan A. Shavit
SLSusan E. Lyons
Susan E. Lyons
The zebrafish is a powerful model for studying vascular development, demonstrating remarkable conservation of this process with mammals. Here, we identify a zebrafish mutant, redhead ( rhd mi149 ), that exhibits embryonic CNS hemorrhage with intact gross development of the vasculature and normal hemostatic function. We show that the rhd phenotype is caused by a hypomorphic mutation in p21-activated kinase 2a ( pak2a ). PAK2 is a kinase that acts downstream of the Rho-family GTPases CDC42 and RAC and has been implicated in angiogenesis, regulation of cytoskeletal structure, and endothelial cell migration and contractility among other functions. Correction of the Pak2a-deficient phenotype by Pak2a overexpression depends on kinase activity, implicating Pak2 signaling in the maintenance of vascular integrity. Rescue by an endothelial-specific transgene further suggests that the hemorrhage seen in Pak2a deficiency is the result of an autonomous endothelial cell defect. Reduced expression of another PAK2 ortholog, pak2b , in Pak2a-deficient embryos results in a more severe hemorrhagic phenotype, consistent with partially overlapping functions for these two orthologs. These data provide in vivo evidence for a critical function of Pak2 in vascular integrity and demonstrate a severe disease phenotype resulting from loss of Pak2 function.

1 February 2008 in Lung Cancer
Verified
Journal Article
Closed access
LZLujun Zhao
Lujun Zhao
KSKerby Sheldon
Kerby Sheldon
MCMing Chen
Ming Chen
MYMoli S. Yin
Moli S. Yin
JHJames A. Hayman
James A. Hayman
FKFeng-Ming Kong
Feng-Ming Kong